Is Gamida Cell Ltd. (NASDAQ:GMDA) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on ...

A downtrend has been apparent in Gamida Cell (GMDA) lately. While the stock has lost 15.6% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last ...

Gamida Cell (NASDAQ:GMDA) stock is taking off on Tuesday after getting an update from the FDA concerning Omisirge. Omisirge is the company’s cell therapy designed to treat patients with hematologic ...

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Gamida Cell (GMDA – Research Report) today and set a price target of $11.00. The company’s shares closed last Friday at $2.05.

Every investor in Gamida Cell Ltd. (NASDAQ:GMDA) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to ...

Major market averages varied in Tuesday's noon session as investors analyzed the latest earnings results from major names including Bank of America, Goldman Sachs and Johnson & Johnson. Teledoc Health ...